CRISPR Therapeutics AG (CRSP)
58.19
+2.20
(+3.93%)
USD |
NASDAQ |
Dec 04, 16:00
58.70
+0.51
(+0.88%)
After-Hours: 20:00
CRISPR Therapeutics Profit Margin (Quarterly): -11.97K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 34.76% |
| Intellia Therapeutics, Inc. | -735.2% |
| Novartis AG | 28.26% |
| Beam Therapeutics, Inc. | -1.16K% |
| BeOne Medicines Ltd. | 8.84% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -26.17% |
| Return on Assets | -22.32% |
| Return on Invested Capital | -23.42% |
| Gross Profit Margin (Quarterly) | -6.82K% |
| Operating Margin (Quarterly) | -14.85K% |
| Return on Net Operating Assets | -177.5% |